Abstract
Von Hippel–Lindau (VHL) disease is an inherited tumor syndrome caused by germline mutations in the VHL tumor suppressor gene. It is characterized by hemangioblastoma in the central nervous system and retina, renal cell carcinoma, pancreatic tumor and cysts, and pheochromocytoma. In this study, we detected 26 germline mutations in the VHL gene of Korean patients, of which 1 was a novel mutation, c.417_418insT. We also integrated our data from this study with the published literature to identify 55 VHL germline mutations in Koreans, and identified a unique hotspot at codon 70. Nine unrelated patients (9/55, 16.4%) had the same amino-acid substitution at codon 70 (Glu70Lys) and showed VHL type 1 phenotypes. Although this mutation was shown to have a mild effect on VHL function, four of the nine patients (44.4%) subsequently developed multiple central nervous system hemangioblastomas or retinal hemangioblastoma. However, this hotspot has not been identified in Chinese or Japanese patients. This study provides information on the spectrum of VHL mutations in Korean VHL disease and contributes to a better understanding of VHL disease in terms of improvements in the clinical management of VHL families.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Maher, E. R. & Kaelin, W. G. von Hippel–Lindau disease. Medicine 76, 381–391 (1997).
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F. M., Orcutt, M. L. et al. Identification of the von Hippel–Lindau disease tumor suppressor gene. Science 260, 1317–1320 (1993).
Maher, E. R., Yates, J. R., Harries, R., Benjamin, C., Harris, R., Moore, A. T. et al. Clinical features and natural history of von Hippel–Lindau disease. Q. J. Med. 77, 1151–1163 (1990).
Nielsen, S. M., Rubinstein, W. S., Thull, D. L., Armstrong, M. J., Feingold, E., Stang, M. T. et al. Genotype–phenotype correlations of pheochromocytoma in two large von Hippel–Lindau (VHL) type 2A kindreds with different missense mutations. Am. J. Med. Genet. A 155A, 168–173 (2011).
Mettu, P., Agron, E., Samtani, S., Chew, E. Y. & Wong, W. T. Genotype–phenotype correlation in ocular von Hippel–Lindau (VHL) disease: the effect of missense mutation position on ocular VHL phenotype. Invest. Ophthalmol. Vis. Sci. 51, 4464–4470 (2010).
Huang, J. S., Huang, C. J., Chen, S. K., Chien, C. C., Chen, C. W. & Lin, C. M. Associations between VHL genotype and clinical phenotype in familial von Hippel–Lindau disease. Eur. J. Clin. Invest. 37, 492–500 (2007).
Yoshida, M., Ashida, S., Kondo, K., Kobayashi, K., Kanno, H., Shinohara, N. et al. Germ-line mutation analysis in patients with von Hippel–Lindau disease in Japan: an extended study of 77 families. Jpn J. Cancer Res. 91, 204–212 (2000).
Wu, P., Zhang, N., Wang, X., Ning, X., Li, T., Bu, D. et al. Family history of von Hippel–Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients. J. Hum. Genet. 57, 238–243 (2012).
Kim, J. H., Cheon, S. H., Oh, C. S., Kim, Y. M. & Park, R. J. Cystic renal cell carcinoma associated with von Hippel–Lindau disease treated by nephron sparing Surgery. Korean J. Urol. 46, 93–95 (2005).
Sohn, B. S., Cho, C. E. & Park, I. Y. Pancreatic cyst in von Hippel–Lindau disease. J. Korean Surg. Soc. 77, 287–290 (2009).
Cho, H. J., Ki, C. S. & Kim, J. W. Improved detection of germline mutations in Korean VHL patients by multiple ligation-dependent probe amplification analysis. J. Korean Med. Sci. 24, 77–83 (2009).
Kim, H. S., Han, B. H., Kim, S. J., Lee, J. S., Park, S. J., Lee, S. U. et al. A case of pancreatic dual Wirsung ducts in a patient with von Hippel–Lindau disease. Korean J. Gastrointest. Endosc. 37, 384–388 (2008).
Seo, J. H., Yang, J. H., Choi, P. L., Kim, Y. L., Choi, Y. S., Park, Y. H. et al. A case of type 1 von Hippel–Lindau (VHL) disease associated with VHL germline mutation. J. Korean Soc. Endocrinol. 21, 239–244 (2006).
Kang, H. C., Kim, I. J., Park, J. H., Shin, Y., Jang, S. G., Ahn, S. A. et al. Three novel VHL germline mutations in Korean patients with von Hippel–Lindau disease and pheochromocytomas. Oncol. Rep. 14, 879–883 (2005).
Kim, J. W., Choi, S. J., Kim, Y. K., Ahn, S. M., Song, K. E., Jung, S. H. et al. A case report of von Hippel–Lindau disease manifested in a monozygous twin. J. Korean Soc. Endocrinol. 20, 395–400 (2005).
Kim, W. T., Ham, W. S., Ju, H. J., Lee, J. S. & Choi, Y. D. Clinical characteristics of renal cell carcinoma in Korean patients with von Hippel–Lindau disease compared to sporadic bilateral or multifocal renal cell carcinoma. J. Korean Med. Sci. 24, 1145–1149 (2009).
Lee, S. H., Park, B. J., Kim, T. S. & Lim, Y. J. Long-term follow-up clinical courses of cerebellar hemangioblastoma in von Hippel–Lindau disease: two case reports and a literature review. J. Korean Neurosurg. Soc. 48, 263–267 (2010).
Myong, N. H. & Park, B. J. Malignant glioma arising at the site of an excised cerebellar hemangioblastoma after irradiation in a von Hippel–Lindau disease patient. Yonsei Med. J. 50, 576–581 (2009).
Shin, K. H., Park, K. J., Kim, S. W., Lee, S. H., Lee, S.-E., Jung, H.-W. et al. Germline mutations of VHL gene in Korean von Hippel–Lindau disease patients. J. Korean Cancer 28, 544–554 (1996).
Yang, J. H., Choi, Y. S., Park, Y. H., Oh, K. S., Chun, B. K., Lee, S. J. et al. A case of von Hippel–Lindau (VHL) germline mutation associated with familial bilateral pheochromocytoma in the VHL disease. Korean J. Med 69, S873–S878 (2005).
Ohn, J. H., Kim, J., Lee, H. J., Seo, W. W., Hwang-Bo, Y., Hong, E. S. et al. A case of von Hippel–Lindau disease presenting with pancreatic neuroendocrine tumor. Endocrinol. Metab. 26, 89–91 (2011).
Clinical Research Group for VHL in Japan. Germline mutations in the von Hippel–Lindau disease (VHL) gene in Japanese VHL. Hum. Mol. Genet. 4, 2233–2237 (1995).
Zbar, B., Kishida, T., Chen, F., Schmidt, L., Maher, E. R., Richards, F. M. et al. Germline mutations in the Von Hippel–Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum. Mutat. 8, 348–357 (1996).
Olschwang, S., Richard, S., Boisson, C., Giraud, S., Laurent-Puig, P., Resche, F. et al. Germline mutation profile of the VHL gene in von Hippel–Lindau disease and in sporadic hemangioblastoma. Hum. Mutat. 12, 424–430 (1998).
Chen, F., Kishida, T., Yao, M., Hustad, T., Glavac, D., Dean, M. et al. Germline mutations in the von Hippel–Lindau disease tumor suppressor gene: correlations with phenotype. Hum. Mutat. 5, 66–75 (1995).
Ritter, M. M., Frilling, A., Crossey, P. A., Hoppner, W., Maher, E. R., Mulligan, L. et al. Isolated familial pheochromocytoma as a variant of von Hippel–Lindau disease. J. Clin. Endocrinol. Metab. 81, 1035–1037 (1996).
Crossey, P. A., Richards, F. M., Foster, K., Green, J. S., Prowse, A., Latif, F. et al. Identification of intragenic mutations in the von Hippel–Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum. Mol. Genet. 3, 1303–1308 (1994).
Stebbins, C. E., Kaelin, W. G. Jr & Pavletich, N. P. Structure of the VHL–ElonginC–ElonginB complex: implications for VHL tumor suppressor function. Science 284, 455–461 (1999).
Forman, J. R., Worth, C. L., Bickerton, G. R., Eisen, T. G. & Blundell, T. L. Structural bioinformatics mutation analysis reveals genotype–phenotype correlations in von Hippel–Lindau disease and suggests molecular mechanisms of tumorigenesis. Proteins 77, 84–96 (2009).
Miller, F., Kentsis, A., Osman, R. & Pan, Z. Q. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL–hypoxia-inducible transcription factor-1alpha complex. J. Biol. Chem. 280, 7985–7996 (2005).
Erlic, Z., Hoffmann, M. M., Sullivan, M., Franke, G., Peczkowska, M., Harsch, I. et al. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel–Lindau syndrome. J. Clin. Endocrinol. Metab. 95, 308–313 (2010).
Dandanell, M., Friis-Hansen, L., Sunde, L., Nielsen, F. C. & Hansen, T. V. Identification of 3 novel VHL germ-line mutations in Danish VHL patients. BMC Med. Genet. 13, 54 (2012).
Young, A. C., Craven, R. A., Cohen, D., Taylor, C., Booth, C., Harnden, P. et al. Analysis of VHL gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma. Clin. Cancer Res. 15, 7582–7592 (2009).
Stolle, C., Glenn, G., Zbar, B., Humphrey, J. S., Choyke, P., Walther, M. et al. Improved detection of germline mutations in the von Hippel–Lindau disease tumor suppressor gene. Hum. Mutat. 12, 417–423 (1998).
Rocha, J. C., Silva, R. L., Mendonca, B. B., Marui, S., Simpson, A. J. & Camargo, A. A. High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil. J. Med. Genet. 40, e31 (2003).
Cybulski, C., Krzystolik, K., Murgia, A., Gorski, B., Debniak, T., Jakubowska, A. et al. Germline mutations in the von Hippel–Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene. J. Med. Genet. 39, E38 (2002).
Zhang, J., Huang, Y., Pan, J., Liu, D., Zhou, L., Xue, W. et al. Germline mutations in the von Hippel–Lindau disease (VHL) gene in mainland Chinese families. J. Cancer Res. Clin. Oncol. 134, 1211–1218 (2008).
Siu, W. K., Ma, R. C., Lam, C. W., Mak, C. M., Yuen, Y. P., Lo, F. M. et al. Molecular basis of von Hippel–Lindau syndrome in Chinese patients. Chin. Med. J. (Engl) 124, 237–241 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Hwang, S., Ku, C., Lee, J. et al. Germline mutation of Glu70Lys is highly frequent in Korean patients with von Hippel–Lindau (VHL) disease. J Hum Genet 59, 488–493 (2014). https://doi.org/10.1038/jhg.2014.61
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2014.61
This article is cited by
-
Von Hipple-Lindau disease complicated with central retinal vein occlusion: a case report
BMC Ophthalmology (2022)
-
Genotype phenotype correlation in Asian Indian von Hippel–Lindau (VHL) syndrome patients with pheochromocytoma/paraganglioma
Familial Cancer (2018)
-
Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma
BMC Medical Genetics (2016)
